Rolf A. Classon, Director at ENZON PHARMACEUTICALS INC (ENZN), bought 10,000 shares at $4.05 ($41K) on 2008-11-17, disclosed to the SEC on 2008-11-18.
Open-market purchase of $41k ENZN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.01 | 1,000 | $4K | 9.9% |
| 2 | $4.02 | 700 | $3K | 6.9% |
| 3 | $4.03 | 400 | $2K | 4.0% |
| 4 | $4.04 | 500 | $2K | 5.0% |
| 5 | $4.05 | 300 | $1K | 3.0% |
| 6 | $4.06 | 1,600 |
| $6K |
| 16.0% |
| 7 | $4.07 | 5,500 | $22K | 55.2% |
| Total | $4.06 avg | 10,000 | $41K | 100% |
| Filing → |
| AUXL | SELL | 2014-12-04 | $9.4M | — | Filing → |
| AUXL | SELL | 2014-03-06 | $319K | — | Filing → |
| HRC | SELL | 2012-12-17 | $214K | — | Filing → |